|
"thaçi diamant"的相關文件
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2022-09-20T00:48:42Z |
Comparing abrocitinib and dupilumab in the treatment of atopic dermatitis: a plain language summary
|
Bieber, Thomas; Simpson, Eric L; Silverberg, Jonathan I; Thaçi, Diamant; Paul, Carle; Pink, Andrew E; Kataoka, Yoko; CHIA-YU CHU; DiBonaventura, Marco; et al., |
| 臺大學術典藏 |
2021-09-08T01:25:02Z |
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
|
Guttman-Yassky, Emma; Teixeira, Henrique D.; Simpson, Eric L.; Papp, Kim A.; Pangan, Aileen L.; Blauvelt, Andrew; Thaçi, Diamant; CHIA-YU CHU; Hong, H. Chih ho; Katoh, Norito; Paller, Amy S.; Calimlim, Brian; Gu, Yihua; Hu, Xiaofei; Liu, Meng; Yang, Yang; Liu, John; Tenorio, Allan R.; Chu, Alvina D.; Irvine, Alan D. |
| 臺大學術典藏 |
2021-09-07T08:35:09Z |
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
|
Bieber, Thomas; Simpson, Eric L; Silverberg, Jonathan I; Thaçi, Diamant; Paul, Carle; Pink, Andrew E; Kataoka, Yoko; CHIA-YU CHU; DiBonaventura, Marco; Rojo, Ricardo; Antinew, Jeremias; Ionita, Ileana; Sinclair, Rodney; Forman, Seth; Zdybski, Jacek; Biswas, Pinaki; Malhotra, Bimal; Zhang, Fan; Valdez, Hernan |
| 臺大學術典藏 |
2019-09-16T09:25:17Z |
Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial
|
Thompson, Elizabeth H.Z.;Williams, David A.;Krueger, James G.;Ryan, Caitriona;Flack, Mary;TSEN-FANG TSAI;Reich, Kristian;Gu, Y.;Paul, C.;Thaçi, Diamant;Gooderham, Melinda;Crowley, Jeffrey J.; Crowley, Jeffrey J.; Gooderham, Melinda; Thaci, Diamant; Paul, C.; Gu, Y.; Reich, Kristian; TSEN-FANG TSAI; Flack, Mary; Ryan, Caitriona; Krueger, James G.; Williams, David A.; Thompson, Elizabeth H.Z. |
| 臺大學術典藏 |
2019-09-16T09:25:17Z |
Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial
|
Thompson, Elizabeth H.Z.;Williams, David A.;Krueger, James G.;Ryan, Caitriona;Flack, Mary;TSEN-FANG TSAI;Reich, Kristian;Gu, Y.;Paul, C.;Thaçi, Diamant;Gooderham, Melinda;Crowley, Jeffrey J.; Crowley, Jeffrey J.; Gooderham, Melinda; Thaci, Diamant; Paul, C.; Gu, Y.; Reich, Kristian; TSEN-FANG TSAI; Flack, Mary; Ryan, Caitriona; Krueger, James G.; Williams, David A.; Thompson, Elizabeth H.Z. |
| 國立臺灣大學 |
2015 |
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
|
Thaci, Diamant; Blauvelt, Andrew; Reich, Kristian; Tsai, Tsen-Fang; Vanaclocha, Francisco; Kingo, Kuelli; Ziv, Michael; Pinter, Andreas; Hugot, Sophie; You, Ruquan; Milutinovic, Marina; 蔡呈芳 |
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
|
